A Study of the C3 Complement Inhibitor AMY-101 in Adults With Gingivitis

NCT03694444 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Gingivitis

Interventions

DRUG: AMY-101
OTHER: Water for injection

Sponsor

Amyndas Pharmaceuticals S.A.